News & Analysis on Clinical Trial Services & Contract Research And Development
The UK-based CRO anticipates that its FY19 earnings results will be “significantly behind current market expectations,” due to increasing competition and pricing pressures.
Juniper Pharmaceuticals will become a wholly owned subsidiary of Catalent Pharma Solutions today, says the CDMO.
Collaboration and cross-selling across Syneos Health's clinical and commercial organizations drove a record quarter marked by new strategic relationships as customers look to increase outsourcing in response to pricing pressures.
Artios Pharma has raised $84m in series B financing to advance small molecule DNA damage response therapies.
Lexaira Bioscience says its DehydraTECH platform has demonstrated significant improvements to the bioavailability of cannabinoids, and could be applied to other pharmaceuticals.
When opened, the seal displays an irreversible holographic effect for tamper evidence and counterfeiting protection.